New pancreatic cancer drug carries a 39800 monthly list price What to know Yahoo Finance

New pancreatic cancer drug carries a 39800 monthly list price What to know  Yahoo Finance

A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA.  Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, redu… [+4982 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *